1940 related articles for article (PubMed ID: 8274294)
1. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
McDonald VL; Dick KO; Malik N; Shoyab M
Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
3. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
4. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
Brown TJ; Lioubin MN; Marquardt H
J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
8. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
Terada S; Suzuki E; Ueda H; Makishima F
Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
[TBL] [Abstract][Full Text] [Related]
9. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity.
Borsellino N; Bonavida B; Ciliberto G; Toniatti C; Travali S; D'Alessandro N
Cancer; 1999 Jan; 85(1):134-44. PubMed ID: 9921985
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
Silvani A; Ferrari G; Paonessa G; Toniatti C; Parmiani G; Colombo MP
Cancer Res; 1995 May; 55(10):2200-5. PubMed ID: 7743524
[TBL] [Abstract][Full Text] [Related]
11. IL-6 signals inhibition of cell adhesion in melanoma A375-C6.
Schwabe M; Deryugina EI; Bosco MC; Gusella GL; Reinisch W; Kung HF; Bourdon MA
Anticancer Res; 1996; 16(6B):3363-70. PubMed ID: 9042193
[TBL] [Abstract][Full Text] [Related]
12. Human interleukin 1 is a cytocidal factor for several tumor cell lines.
Onozaki K; Matsushima K; Aggarwal BB; Oppenheim JJ
J Immunol; 1985 Dec; 135(6):3962-8. PubMed ID: 2415593
[TBL] [Abstract][Full Text] [Related]
13. A ciliary neurotrophic factor-sensitive human myeloma cell line.
Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts.
Richards CD; Langdon C; Botelho F; Brown TJ; Agro A
J Immunol; 1996 Jan; 156(1):343-9. PubMed ID: 8598483
[TBL] [Abstract][Full Text] [Related]
15. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
[TBL] [Abstract][Full Text] [Related]
16. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375.
Hattori T; Hayashi H; Chiba T; Onozaki K
Eur Cytokine Netw; 2001; 12(2):244-52. PubMed ID: 11399512
[TBL] [Abstract][Full Text] [Related]
17. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.
Heymann D; Godard A; Raher S; Ringeard S; Lassort D; Blanchard F; Harb J
Cytokine; 1995 Feb; 7(2):111-7. PubMed ID: 7780030
[TBL] [Abstract][Full Text] [Related]
18. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M inhibits decidualization of normal human endometrial stromal cells.
Tanaka T; Umesaki N
Int J Mol Med; 2003 May; 11(5):627-30. PubMed ID: 12684701
[TBL] [Abstract][Full Text] [Related]
20. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M.
Liu J; Clegg CH; Shoyab M
Cell Growth Differ; 1992 May; 3(5):307-13. PubMed ID: 1633113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
